Format
Sort by
Items per page

Send to

Choose Destination

Best matches for carnitine AND hiv infections:

Search results

Items: 1 to 20 of 95

1.

WITHDRAWN: Interventions for fatigue and weight loss in adults with advanced progressive illness.

Payne C, Wiffen PJ, Martin S.

Cochrane Database Syst Rev. 2017 Apr 7;4:CD008427. doi: 10.1002/14651858.CD008427.pub3. Review.

PMID:
28387447
2.

Superior Glucose Tolerance and Metabolomic Profiles, Independent of Adiposity, in HIV-Infected Women Compared With Men on Antiretroviral Therapy.

Koethe JR, Jenkins CA, Petucci C, Culver J, Shepherd BE, Sterling TR.

Medicine (Baltimore). 2016 May;95(19):e3634. doi: 10.1097/MD.0000000000003634.

3.

Low levels of short- and medium-chain acylcarnitines in HIV-infected patients.

Waagsbø B, Svardal A, Ueland T, Landrø L, Øktedalen O, Berge RK, Flo TH, Aukrust P, Damås JK.

Eur J Clin Invest. 2016 May;46(5):408-17. doi: 10.1111/eci.12609. Epub 2016 Mar 7.

PMID:
26913383
4.

Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States.

Kirmse B, Yao TJ, Hofherr S, Kacanek D, Williams PL, Hobbs CV, Hazra R, Borkowsky W, Van Dyke RB, Summar M.

AIDS Res Hum Retroviruses. 2016 Apr;32(4):339-48. doi: 10.1089/AID.2015.0112. Epub 2016 Jan 19.

5.

Altered Monoamine and Acylcarnitine Metabolites in HIV-Positive and HIV-Negative Subjects With Depression.

Cassol E, Misra V, Morgello S, Kirk GD, Mehta SH, Gabuzda D.

J Acquir Immune Defic Syndr. 2015 May 1;69(1):18-28. doi: 10.1097/QAI.0000000000000551.

6.

A review of the toxicity of HIV medications.

Margolis AM, Heverling H, Pham PA, Stolbach A.

J Med Toxicol. 2014 Mar;10(1):26-39. doi: 10.1007/s13181-013-0325-8. Review.

7.

Frequency of depression and its correlation with serum carnitine level in HIV/AIDS patients.

Rezaee H, Khalili H, Hatamkhani S, Dashti-Khavidaki S, Khazaeipour Z.

Curr HIV Res. 2013 Apr;11(3):226-30.

PMID:
23574341
8.

Abnormal newborn screens and acylcarnitines in HIV-exposed and ARV-exposed infants.

Kirmse B, Hobbs CV, Peter I, Laplante B, Caggana M, Kloke K, Raymond K, Summar M, Borkowsky W.

Pediatr Infect Dis J. 2013 Feb;32(2):146-50. doi: 10.1097/INF.0b013e31827030a6.

9.

Interventions for fatigue and weight loss in adults with advanced progressive illness.

Payne C, Wiffen PJ, Martin S.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008427. doi: 10.1002/14651858.CD008427.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Apr 07;4:CD008427.

PMID:
22258985
10.

Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials.

Phillips TJ, Cherry CL, Cox S, Marshall SJ, Rice AS.

PLoS One. 2010 Dec 28;5(12):e14433. doi: 10.1371/journal.pone.0014433. Review.

11.

Effect of antioxidants on mitochondrial function in HIV-1-related lipoatrophy: a pilot study.

Milazzo L, Menzaghi B, Caramma I, Nasi M, Sangaletti O, Cesari M, Zanone Poma B, Cossarizza A, Antinori S, Galli M.

AIDS Res Hum Retroviruses. 2010 Nov;26(11):1207-14. doi: 10.1089/aid.2010.0024. Epub 2010 Oct 26.

PMID:
20977356
12.

Acetyl-L-carnitine. Monograph.

[No authors listed]

Altern Med Rev. 2010 Apr;15(1):76-83. Review. No abstract available.

13.

Ubisol-Aqua: coenzyme Q10 prevents antiretroviral toxic neuropathy in an in vitro model.

Cherry CL, Mobarok M, Wesselingh SL, Fain R, Weinstock S, Tachedjian G, Srivastava S, Tyssen DP, Glass JD, Hooker DJ.

Curr HIV Res. 2010 Apr;8(3):232-9.

PMID:
20158454
14.

Effect of L-acetylcarnitine on body composition in HIV-related lipodystrophy.

Benedini S, Perseghin G, Terruzzi I, Scifo P, Invernizzi PL, Del Maschio A, Lazzarin A, Luzi L.

Horm Metab Res. 2009 Nov;41(11):840-5. doi: 10.1055/s-0029-1225625. Epub 2009 Jul 13.

PMID:
19598076
15.

Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection.

Valcour V, Yeh TM, Bartt R, Clifford D, Gerschenson M, Evans SR, Cohen BA, Ebenezer GJ, Hauer P, Millar L, Gould M, Tran P, Shikuma C, Souza S, McArthur JC; AIDS Clinical Trials Group (ACTG) 5157 protocol team.

HIV Med. 2009 Feb;10(2):103-10. doi: 10.1111/j.1468-1293.2008.00658.x.

16.

Nonvitamin, nonmineral dietary supplementation in HIV-positive people.

Sansevero MR, Houser R, Phelan G, Wanke C, Tang A, Hendricks K.

Nutr Clin Pract. 2007 Dec;22(6):679-87.

PMID:
18042957
17.

Acetyl-L-carnitine in HIV-associated antiretroviral toxic neuropathy.

Youle M.

CNS Drugs. 2007;21 Suppl 1:25-30; discussion 45-6. Review.

PMID:
17696590
18.

Managing HIV peripheral neuropathy.

Gonzalez-Duarte A, Cikurel K, Simpson DM.

Curr HIV/AIDS Rep. 2007 Aug;4(3):114-8. Review.

PMID:
17883996
20.

Complications & side effects. Supplements and CD4+ counts: study finds surprising results.

[No authors listed]

TreatmentUpdate. 2004 Mar;16(2):4-6. No abstract available.

PMID:
17219668

Supplemental Content

Loading ...
Support Center